The Effects of Haemodilution with Hydroxyethyl Starch 130/0.4 Solution on Coagulation as Assessed by Thromboelastography and Platelet Receptor Function Studies in Vitro
Free accessResearch articleFirst published online November, 2015
The Effects of Haemodilution with Hydroxyethyl Starch 130/0.4 Solution on Coagulation as Assessed by Thromboelastography and Platelet Receptor Function Studies in Vitro
This study evaluated the effects of haemodilution with either 6% hydroxyethyl starch (HES) 130/0.4 (Voluven®) or 0.9% normal saline (NS) on blood coagulation in vitro. Haemodilution with 6% HES 130/0.4 impaired coagulation, as indicated by the changes in thromboelastographic parameters k-time, α-angle and maximum amplitude. Light transmission aggregometry and multiple electrode aggregometry demonstrated that impaired platelet receptor function occurred only at high levels of haemodilution (40%) with both fluids, but there was no significant difference between the two fluids (P=0.05). The thromboelastographic functional fibrinogen assay showed that the fibrinogen component of clot strength was significantly impaired with haemodilution with HES 130/0.4 compared with haemodilution with NS (whole blood [14.4±4.6 mm] versus 40% HES dilution [3.7±1.9], [P=0.001]; versus 40% NS dilution [10.4±4.6], [P=0.129]). These findings suggest that there is little difference between HES or NS in relation to coagulation or platelet function during minor or moderate haemodilution, but at high levels of haemodilution with HES, fibrinogen activity is more impaired compared with NS.
de JongeE., LeviM.Effects of different plasma substitutes on blood coagulation: a comparative review.Crit Care Med2001; 29: 1261–1267.
2.
WestphalM., JamesM.F.M., Kozek-LangeneckerS., StockerR., GuidetB., Van AkenH.Hydroxyethyl starches: different products-different effects.Anesthesiology2009; 111: 187–202.
3.
LangeronO., DoelbergM., AngE.T., BonnetF., CapdevilaX., CoriatP.Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5.Anesth Analg2001; 92: 855–862.
4.
KonradC.J., MarklT.J., SchuepferG.K., SchmeckJ., GerberH.R.In vitro effects of different medium molecular hydroxyethyl starch solutions and lactated Ringer's solution on coagulation using SONOCLOT.Anesth Analg2000; 90: 274–279.
5.
Kozek-LangeneckerS.A., JungheinrichC., SauermannW., Van der LindenP.The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials.Anesth Analg2008; 107: 382–390.
6.
GattasD.J., DanA., MyburghJ., BillotL., LoS., FinferS.Fluid resuscitation with 6% hydroxyethyl starch (130/0.4) in acutely ill patients: an updated systematic review and meta-analysis.Anesth Analg2012; 114: 159–169.
7.
HaaseN., PernerA., HenningsL.I., SiegemundM., LauridsenB., WetterslevM.Hydroxyethyl starch 130/0.38–0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis.BMJ2013; 346: f839.
8.
HartogC.S., ReuterD., LoescheW., HofmannM., ReinhartK.Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review.Intensive Care Med2011; 37: 1725–1737.
9.
MammenE.F., CompP.C., GosselinR., GreenbergC., HootsW.K., KesslerC.M.PFA-100 system: a new method for assessment of platelet dysfunction.Semin Thromb Hemost1998; 24: 195–202.
ZambruniA., ThalheimerU., LeandroG., PerryD., BurroughsA.K.Thromboelastography with citrated blood: comparability with native blood, stability of citrate storage and effect of repeated sampling.Blood Coagul Fibrinolysis2004; 15: 103–107.
12.
HarrJ.N., MooreE.E., GhasabyanA., ChinT.L., SauaiaA., BanerjeeA.Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma.Shock2013; 39: 45–49.
13.
FlugerI., MaderovaK., SimekM., HajekR., ZapletalovaJ., LonskyV.Comparison of functional fibrinogen assessment using thromboelastography with the standard von Clauss method.Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub2012; 156: 260–261.
14.
CarrollR.C., CraftR.M., ChavezJ.J., SniderC.C., KirbyR.K., CohenE.Measurement of functional fibrinogen levels using the Thrombelastograph.J Clin Anesth2008; 20: 186–190.
15.
CattaneoM.Light transmission aggregometry and ATP release for the diagnostic assessment of platelet function.Semin Thromb Hemost2009; 35: 158–167.
ZhouL., SchmaierA.H.Platelet aggregation testing in platelet-rich plasma: description of procedures with the aim to develop standards in the field.Am J Clin Pathol2005; 123: 172–183.
18.
TothO., CalatzisA., PenzS., LosonczyH., SiessW.Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood.Thromb Haemost2006; 96: 781–788.
RocheA.M., JamesM.F.M., Bennett-GuerreroE., MythenM.G.A head-to-head comparison of the in vitro coagulation effects of saline-based and balanced electrolyte crystalloid and colloid intravenous fluids.Anesth Analg2006; 102: 1274–1279.
21.
CasuttM., KristoffyA., SchuepferG., SpahnD.R., KonradC.Effects on coagulation of balanced (130/0.42) and non-balanced (130/0.4) hydroxyethyl starch or gelatin compared with balanced Ringer's solution: an in vitro study using two different viscoelastic coagulation tests ROTEMTM and SONOCLOTTM.Br J Anaesth2010; 105: 273–281.
22.
SchadenE., WetzelL., Kozek-LangeneckerS., ThalerU., ScharbertG.Effect of the carrier solution for hydroxyethyl starch on platelet aggregation and clot formation.Br J Anaesth2012; 109: 572–577.
23.
SolomonC., SorensenB., HochleitnerG., KashukJ., RanucciM., SchochlH.Comparison of whole blood fibrin-based clot tests in thrombelastography and thromboelastometry.Anesth Analg2012; 114: 721–730.
24.
EgliG.A., ZollingerA., SeifertB., PopovicD., PaschT., SpahnD.R.Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation.Br J Anaesth1997; 78: 684–689.
25.
PetroianuG.A., LiuJ., MaleckW.H., MattingerC., BerglerW.F.The effect of In vitro hemodilution with gelatin, dextran, hydroxyethyl starch, or Ringer's solution on Thrombelastograph.Anesth Analg2000; 90: 795–800.
26.
FranzA., BraunlichP., GamsjagerT., FelfernigM., GustorffB., Kozek-LangeneckerS.A.The effects of hydroxyethyl starches of varying molecular weights on platelet function.Anesth Analg2001; 92: 1402–1407.
27.
InnerhoferP., FriesD., MargreiterJ., KlinglerA., KuhbacherG., WachterB.The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation.Anesth Analg2002; 95: 858–865.
28.
ThalerU., DeuschE., Kozek-LangeneckerS.A.In vitro effects of gelatin solutions on platelet function: a comparison with hydroxyethyl starch solutions.Anaesthesia2005; 60: 554–559.
De LorenzoC., CalatzisA., WelschU., HeindlB.Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%.Anesth Analg2006; 102: 1194–200.
33.
WinstedtD., TynngardN., OlandersK., SchottU.Free oscillation rheometry monitoring of haemodilution and hypothermia and correction with fibrinogen and factor XIII concentrates.Scand J Trauma Resusc Emerg Med2013; 21: 20.
34.
Fenger-EriksenC., JensenT.M., KristensenB.S., JensenK.M., TonnesenE., IngerslevJ.Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial.J Thromb Haemost2009; 7: 795–802.
35.
Fenger-EriksenC., MooreG.W., RangarajanS., IngerslevJ., SorensenB.Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders.Transfusion2010; 50: 2571–2576.
36.
NielsenV.G.Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions.Acta Anaesthesiol Scand2005; 49: 1163–1171.
37.
FriesD., InnerhoferP.A., ReifC., StreifW.R., KlinglerA., SchobersbergerW.The effect of fibrinogen substitution on reversal of dilutional coagulopathy: an in vitro model.Anesth Analg2006; 102: 347–351.
38.
Fenger-EriksenC., Anker-MollerE., HeslopJ., IngerslevJ., SorensenB.Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate.Br J Anaesth2005; 94: 324–329.
39.
PernerA., HaaseN., GuttormsenA.B., TenhunenJ., KlemenzsonG., AnemanA.Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.N Engl J Med2012; 367: 124–134.
40.
MyburghJ.A., FinferS., BellomoR., BillotL., CassA., GattasD.Hydroxyethyl starch or saline for fluid resuscitation in intensive care.N Engl J Med2012; 367: 1901–1911.
41.
ZuckermanL., CohenE., VagherJ.P., WoodwardE., CapriniJ.A.Comparison of thrombelastography with common coagulation tests.Thromb Haemost1981; 46: 752–756.
42.
OgawaS., OhnishiT., HosokawaK., SzlamF., ChenE.P., TanakaK.A.Haemodilution-induced changes in coagulation and effects of haemostatic components under flow conditions.Br J Anaesth2013; 111: 1013–1023.
